Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
---|---|---|---|---|---|---|---|---|---|---|
|
A | 0.700 | CausalMutation | CLINVAR | ||||||
|
A | 0.700 | CausalMutation | CLINVAR | ||||||
|
A | 0.700 | CausalMutation | CLINVAR | ||||||
|
AAGAACACAGGGGAGAGCA | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
C | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | ||||||
|
G | 0.700 | CausalMutation | CLINVAR | Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase/AKT/glycogen synthase kinase 3beta signaling. | 20308328 | 2010 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. | 21407260 | 2011 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Cochlear implantation and clinical features in patients with Noonan syndrome and Noonan syndrome with multiple lentigines caused by a mutation in PTPN11. | 28483241 | 2017 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies. | 26785492 | 2015 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation. | 18253957 | 2008 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Negative regulation of Stat3 by activating PTPN11 mutants contributes to the pathogenesis of Noonan syndrome and juvenile myelomonocytic leukemia. | 19509418 | 2009 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes. | 15987685 | 2005 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation. | 14974085 | 2004 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Novel mutations and their genotype-phenotype correlations in patients with Noonan syndrome, using next-generation sequencing. | 28957739 | 2018 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. | 11704759 | 2001 |
|||
|
G | 0.700 | CausalMutation | CLINVAR | Age-dependent germline mosaicism of the most common noonan syndrome mutation shows the signature of germline selection. | 23726368 | 2013 |